Wave Life Sciences Ltd(NASDAQ:WVE) 
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides target ribonucleic acid to reduce the expression of ...
Website: http://www.wavelifesciences.com
Founded: 2012
Full Time Employees: 301
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 6.70
H 6.76
L 5.84
C 6.03
V 2,419,565
10EMA 6.03
20EMA 6.03
60EMA 6.03
120EMA 6.03
250EMA 6.03